SCHEMBL9534241

SCHEMBL9534241

COc1cccc2c(=O)n3ccsc3nc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 2/20 0.50
L3MBTL1 Q9Y468 1/20 0.45
CYP1A2 P05177 2/20 0.43
TDP1 Q9NUW8 1/20 0.43
LMNA P02545 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C19 P33261 1/20 0.43
MAPT P10636 1/20 0.41
KMT2A Q03164 1/20 0.41
CYP1A1 P04798 1/20 0.41
CYP1B1 Q16678 1/20 0.41
ADORA2A P29274 1/20 0.41
TNKS O95271 4/20 0.41
TNKS2 Q9H2K2 4/20 0.41
PARP2 Q9UGN5 2/20 0.41
TSHR P16473 1/20 0.41
KDM4E B2RXH2 2/20 0.40
ALDH1A1 P00352 2/20 0.40
HPGD P15428 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9534426 0.86 ALDH1A1 (0.43) PKML3MBTL1CYP1A2TDP1LMNA
SCHEMBL9537313 0.82 GAA (0.52) PKMCYP1A2TDP1LMNAMAPT
SCHEMBL9536991 0.79 CYP1A2 (0.50) PKML3MBTL1CYP1A2TDP1LMNA
SCHEMBL9770496 0.79 CYP1A2 (0.43) PKMCYP1A2TDP1LMNAKMT2A
SCHEMBL9535677 0.79 TDP1 (0.50) PKML3MBTL1CYP1A2TDP1LMNA
SCHEMBL9534033 0.78 PKM (0.50) PKML3MBTL1CYP1A2TDP1LMNA
SCHEMBL10696259 0.78 CYP1A2 (0.43) PKML3MBTL1CYP1A2TDP1LMNA
SCHEMBL9533606 0.76 TNKS (0.43) CYP1A2MAPTCYP1A1CYP1B1ADORA2A
SCHEMBL9536686 0.75 KDM4E (0.59) CYP1A2MAPTKMT2ACYP1A1CYP1B1
SCHEMBL6704339 0.72 KDM4E (0.54) L3MBTL1CYP1A2TDP1LMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0263523-B1 Process for the preparation of thiazolo [2,3-b] quinazolones BASF AG (DE) 1993-12-29 EP disclosed
US-5030727-A Reacting an anthronilide derivative with a thiazole derivative or a fluorozuinazolone with a neucleophile BASF AKTIENGESELLSCHAFT (DE) 1991-07-09 US disclosed
EP-0263523-A2 Process for the preparation of thiazolo [2,3-b] quinazolones BASF Aktiengesellschaft (DE) 1988-04-13 EP disclosed